Apatinib mesylate tablet in the treatment of advanced malignant melanoma

BACKGROUND: Observing and studying clinical efficacy and safety of apatinib mesylate tablet in the treatment of advanced malignant melanoma (MM). METHODS: Retrospectively analyzing the clinical data of 22 patients with metastatic MM who had failed conventional chemotherapy from June 2016 to January...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Lingge, Zhu, Huiyan, Luo, Peng, Chen, Shiqi, Xu, Yu, Wang, Chunmeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6126500/
https://www.ncbi.nlm.nih.gov/pubmed/30214239
http://dx.doi.org/10.2147/OTT.S175507

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6126500/
https://www.ncbi.nlm.nih.gov/pubmed/30214239
http://dx.doi.org/10.2147/OTT.S175507

Ejemplares similares